跳至主要内容
临床试验/IRCT20220424054636N1
IRCT20220424054636N1招募中未知

Comparing the effect of Prolotherapy with Placebo, in patients with diabetic foot ulcer

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age > 18 years old
  • Patients with confirmed type 1 or 2 diabetes mellitus
  • HbA1C = 7-10%
  • Ability to understand and collaborate during the study
  • Having at least one chronic ulcer lasting for more than 4 weeks
  • Plantar or dorsal or malleolar ulceration
  • ABI = 0.7 - 1.2 in ischemic ulcers
  • Ulcers with Wagner grades 2, 3
  • Ulcers with wound area = 1-20 cm2
  • None of the patients had received glucocorticoid, estrogen, or other drugs that interfere healing process within the past 1 month
  • Patients who signed the informed consent

排除标准

  • Patients with a history of malignancy or coagulopathy
  • GFR < 30 ml/min/1.73m2
  • Albumin level < 3.5 g/dl

研究者

相似试验